Grown Rogue International (GRUSF) Cash from Investing Activities (QoQ) (2013 - 2026)
Grown Rogue International (GRUSF) Cash from Investing Activities (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.00% |
| Mar 31, 2025 | 82.27% |
| Dec 31, 2024 | 22.81% |
| Sep 30, 2024 | -11.41% |
| Jun 30, 2024 | 9.09% |
| Oct 31, 2023 | -130.95% |
| Jul 31, 2023 | -112.23% |
| Apr 30, 2023 | -1,490.46% |
| Jan 31, 2022 | 100.00% |
| Oct 31, 2021 | -10,537,729.82% |
| Jul 31, 2021 | -312.33% |
| Apr 30, 2021 | 1,249.77% |
| Jan 31, 2021 | 87.69% |
| Oct 31, 2020 | -807.28% |
| Jul 31, 2020 | -60.70% |
| Apr 30, 2020 | 10,361.17% |
| Jan 31, 2020 | -124.22% |
| Oct 31, 2019 | 130.93% |
| Jul 31, 2019 | 56.16% |
| Apr 30, 2019 | -69.09% |